Search results for "erythrocytes"

showing 10 items of 218 documents

Electron Microscopy of Human Erythrocyte Catalase: New Two-Dimensional Crystal Forms

1993

Abstract Using the mica-spreading "negative staining-carbon film" procedure, human erythrocyte catalase has been shown to create a number of different periodic or crystalline two-dimensional (2-D) arrays which differ in the arrangement of molecules in the repeating units and the lattice type. Digital image processing has been performed with a 2-D array which contains regularly arranged "undulating" rows of molecules and also with a 2-D crystal form, exhibiting pgg (p22 1 2 1 ) symmetry and lattice parameters of a = 12.7 nm, b = 44 nm, and γ= 92°. The data are compared with our previous analysis of a different human erythrocyte catalase 2-D crystal, and the effect of partial-depth negative s…

Models MolecularErythrocytesFourier AnalysisbiologyMolecular modelProtein ConformationChemistryStereochemistryCatalaseNegative stainlaw.inventionCrystalMicroscopy ElectronCrystallographyStructural BiologyCatalaseTransmission electron microscopylawLattice (order)biology.proteinHumansMoleculeComputer SimulationElectron microscopeJournal of Structural Biology
researchProduct

In vitro leishmanicidal activity of pyrazole-containing polyamine macrocycles which inhibit the Fe-SOD enzyme of Leishmania infantum and Leishmania b…

2014

The in vitro leishmanicidal activity and cytotoxicity of pyrazole-containing macrocyclic polyamines 1-4 was assayed on Leishmania infantum and Leishmania braziliensis species. Compounds 1-4 were more active and less toxic than glucantime and both infection rates and ultrastructural alterations confirmed that 1 and 2 were highly leishmanicidal and induced extensive parasite cell damage. Modifications in the excretion products of parasites treated with 1-3 were also consistent with substantial cytoplasm alterations. Compound 2 was highlighted as a potent inhibitor of Fe-SOD in both species, whereas its effect on human CuZn-SOD was poor. Molecular modelling suggested that 2 could deactivate Fe…

Models MolecularLeishmanicidal activityErythrocytesMacrocyclic CompoundsAntioxidantCell Survivalmedicine.medical_treatmentAntiprotozoal AgentsProtozoan ProteinsBiologyLeishmania braziliensisCell LinePolyamine macrocyclechemistry.chemical_compoundMicroscopy Electron TransmissionIron superoxide dismutasePolyaminesmedicineAnimalsHumansLeishmania infantumCytotoxicityLeishmaniasischemistry.chemical_classificationMice Inbred BALB CSuperoxide DismutaseMacrophagesbiology.organism_classificationLeishmania braziliensisIn vitroInfectious DiseasesEnzymechemistryBiochemistryCell culturePyrazolePyrazolesFemaleAnimal Science and ZoologyParasitologyLeishmania infantumPolyamineParasitology
researchProduct

Formation, TEM study and 3D reconstruction of the human erythrocyte peroxiredoxin-2 dodecahedral higher-order assembly.

2004

The production of a higher-order assembly of peroxiredoxin-2 (Prx-2) from human erythrocytes has been achieved during specimen preparation on holey carbon support films, in the presence of ammonium molybdate and polyethylene glycol. TEM study suggested that this assembly is a regular dodecahedron, containing 12 Prx-2 decamers (Mr 2.62 MDa, external diameter approximately 20 nm). This interpretation has been supported by production of a approximately 1.6 nm 3D reconstruction from the negative stain TEM data, with automated docking of the available X-ray data of the Prx-2 decamer. Comparison with other known protein dodecahedral and viral icosahedral structures indicates that this arrangement…

Models MolecularMaterials scienceErythrocytesIcosahedral symmetryMacromolecular SubstancesMacromolecular SubstancesGeneral Physics and AstronomyCell BiologyPeroxiredoxin 2Polyethylene glycolPeroxiredoxinsNegative stainDodecahedronCrystallographychemistry.chemical_compoundProtein structurechemistryMicroscopy Electron TransmissionPeroxidasesStructural BiologyImage Processing Computer-AssistedHumansGeneral Materials ScienceProtein Structure QuaternaryMacromoleculeMicron (Oxford, England : 1993)
researchProduct

Comparison of the decameric structure of peroxiredoxin-II by transmission electron microscopy and X-ray crystallography

2001

Abstract The decameric human erythrocyte protein torin is identical to the thiol-specific antioxidant protein-II (TSA-II), also termed peroxiredoxin-II (Prx-II). Single particle analysis from electron micrographs of Prx-II molecules homogeneously orientated across holes in the presence of a thin film of ammonium molybdate and trehalose has facilitated the production of a ≥20 A 3-D reconstruction by angular reconstitution that emphasises the D5 symmetry of the ring-like decamer. The X-ray structure for Prx-II was fitted into the transmission electron microscopic reconstruction by molecular replacement. The surface-rendered transmission electron microscopy (TEM) reconstruction correlates well…

Models MolecularMolybdenumErythrocytesSurface PropertiesCryo-electron microscopyChemistryResolution (electron density)BiophysicsTrehaloseSingle particle analysisPeroxiredoxinsCrystallography X-RayBiochemistryNegative stainMicroscopy ElectronCrystallographyPeroxidasesElectron tomographyStructural BiologyTransmission electron microscopyHumansEnergy filtered transmission electron microscopyOrthorhombic crystal systemMolecular BiologyBiochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology
researchProduct

Tetracycline-controlled transgenic targeting from the SCL locus directs conditional expression to erythrocytes, megakaryocytes, granulocytes, and c-k…

2006

The stem cell leukemia gene SCL, also known as TAL-1, encodes a basic helix-loop-helix transcription factor expressed in erythroid, myeloid, megakaryocytic, and hematopoietic stem cells. To be able to make use of the unique tissue-restricted and spatio-temporal expression pattern of the SCL gene, we have generated a knock-in mouse line containing the tTA-2S tetracycline transactivator under the control of SCL regulatory elements. Analysis of this mouse using different tetracycline-dependent reporter strains demonstrated that switchable transgene expression was restricted to erythrocytes, megakaryocytes, granulocytes, and, importantly, to the c-kit-expressing and lineage-negative cell fracti…

MyeloidErythrocytesGenotypeTransgeneImmunologyMice TransgenicBiologyBiochemistryMiceMegakaryocyteGenes Reporterhemic and lymphatic diseasesProto-Oncogene ProteinsmedicineBasic Helix-Loop-Helix Transcription FactorsAnimalsT-Cell Acute Lymphocytic Leukemia Protein 1DNA PrimersRegulation of gene expressionReporter geneBase SequenceCell BiologyHematologyTetracyclineFlow CytometryMolecular biologyRecombinant ProteinsHematopoiesisHaematopoiesisProto-Oncogene Proteins c-kitmedicine.anatomical_structureGene Expression RegulationBone marrowStem cellMegakaryocytesGranulocytesBlood
researchProduct

Nanoassemblies Based on Supramolecular Complexes of Nonionic Amphiphilic Cyclodextrin and Sorafenib as Effective Weapons to Kill Human HCC Cells

2015

Sorafenib (Sor), an effective chemiotherapeutic drug utilized against hepatocellular carcinoma (HOC), robustly interacts with nonionic amphiphilic cyclodextrin (aCD, SC6OH), forming, in aqueous solution, supramolecular complexes that behave as building blocks of highly water-dispersible colloidal nanoassemblies. SC6OH/Sor complex has been characterized by complementary spectroscopic techniques, such as UV-vis, steady-state fluorescence and anisotropy, resonance light scattering and H-1 NMR. The spectroscopic evidences and experiments carried out in the presence of an adamantane derivative, which competes with drug for CD cavity, agree with the entrapment of Sor in aCD, pointing out the role…

NiacinamideErythrocytesPolymers and PlasticsCell SurvivalAdamantaneDrug CompoundingSupramolecular chemistryBioengineeringNanotechnologyAdamantaneAntineoplastic AgentsBinding CompetitiveHemolysisAmphiphilic Cyclodextrins; Nanoparticles; Sorafenib; HCC cellsHCC cellsBiomaterialschemistry.chemical_compoundSurface-Active AgentsIn vivoCell Line TumorAmphiphileMaterials ChemistryHumanschemistry.chemical_classificationCyclodextrinsAqueous solutionCyclodextrinPhenylurea CompoundsSorafenibFluorescenceCombinatorial chemistrydigestive system diseasesNanostructuresBINDING INTERACTION THERAPY PHARMACOKINETICS BIOAVAILABILITY NANOPARTICLESDrug LiberationKineticsnanoassembliecyclodextrinchemistryDelayed-Action PreparationsProton NMRHepatocytes
researchProduct

Untersuchungen über den Einfluß langkettiger fettsaurer Salze auf Erythrozyten

1969

Natrium-oleat und Olsaure haben spezifische morphologische und funktionelle Wirkungen auf menschliche Erythrozyten in vitro. Eine Erhohung der Konzentration dieser Substanzen im Blut fuhrt zu reversiblen stechapfelformigen Veranderungen der Erythrozytenform, zur Hemmung der Blutkorperchensenkungsgeschwindigkeit und zur Senkung der Strukturviskositat des Blutes. Weiterhin wird bei Konzentrationen bis 45 mg% die osmotische Resistenz der Erythrozyten verbessert. Erst hohe Konzentrationen an Na-oleat im Blut fuhren zur Hamolyse. Investigations on the Influence of Long Chain Fatty Acid Salts on Erythrocytes Sodium oleate and oleic acid have specific morphological and functional action on human e…

Oleic acidchemistry.chemical_compoundChemistryImmunologySodium oleateHuman erythrocytesHaemolysisMolecular biologyFette, Seifen, Anstrichmittel
researchProduct

Pertuzumab monotherapy after trastuzumab-based treatment and subsequent reintroduction of trastuzumab: activity and tolerability in patients with adv…

2012

Purpose The combination of pertuzumab and trastuzumab resulted in a clinical benefit rate (CBR) of 50% in patients with human epidermal growth factor receptor 2 (HER2) –positive breast cancer whose disease progressed during prior trastuzumab-based therapy. To define whether this previously observed encouraging activity was a result of the combination of pertuzumab and trastuzumab or of pertuzumab alone, we recruited a third cohort of patients who received pertuzumab without trastuzumab. We then investigated the impact of reintroducing trastuzumab to patients whose disease progressed on pertuzumab monotherapy. Patients and Methods Twenty-nine patients with HER2-positive breast cancer whose d…

OncologyCancer ResearchReceptor ErbB-2MESH: Risk AssessmentMESH: Dose-Response Relationship Drug0302 clinical medicineTrastuzumabAntineoplastic Combined Chemotherapy ProtocolsMedicineProspective StudiesProspective cohort studyskin and connective tissue diseasespertuzumab; trastuzumab; breast cancerMESH: Treatment OutcomeMESH: Aged0303 health sciencesMESH: Middle AgedMESH: ErythrocytesAge FactorsMESH: Maximum Tolerated DoseMESH: Neoplasm StagingMiddle AgedPrognosis3. Good healthtrastuzumabMESH: Antineoplastic Combined Chemotherapy ProtocolsTreatment OutcomeOncologyTolerabilityMESH: Receptor erbB-2030220 oncology & carcinogenesisMESH: Survival AnalysisDisease Progression[SDV.IMM]Life Sciences [q-bio]/ImmunologyMESH: Disease ProgressionFemalePertuzumabmedicine.drugAdultmedicine.medical_specialty[SDV.IMM] Life Sciences [q-bio]/ImmunologyMaximum Tolerated DoseMESH: Blood TransfusionBreast NeoplasmsMESH: Drug Administration ScheduleAntibodies Monoclonal HumanizedLoading doseMESH: Cell SeparationRisk AssessmentMESH: PrognosisDisease-Free SurvivalDrug Administration Schedule03 medical and health sciencesbreast cancerBreast cancerMESH: PrionspertuzumabInternal medicineHumansMESH: Patient SelectionNeoplasm InvasivenessneoplasmsSurvival analysis030304 developmental biologyAgedNeoplasm StagingMESH: Age FactorsMESH: HumansDose-Response Relationship Drugbusiness.industryPatient SelectionMESH: AdultMESH: Neoplasm InvasivenessMESH: Creutzfeldt-Jakob SyndromeTrastuzumabmedicine.diseaseSurvival AnalysisMESH: Prospective StudiesMESH: Antibodies Monoclonal HumanizedMESH: Disease-Free SurvivalbusinessMESH: FemaleProgressive diseaseMESH: Breast NeoplasmsJournal of clinical oncology : official journal of the American Society of Clinical Oncology
researchProduct

Der erythrocytäre Magnesiumstoffwechsel bei intakter und kälteinhibierter Glykolyse

1962

Continuation of glycolysis in human erythrocytes by incubation of heparinized whole blood at 37°C is followed by a decrease in the Mg-content of red cells. On inhibition of glycolysis by cold (4°C), the Mg-content of erythrocytes remains unaltered or, often, slightly increases. These actions are in clear contrast to the behaviour of potassium ions under the same conditions.

PharmacologyChemistryMagnesiumchemistry.chemical_elementCell BiologyMetabolismCarbohydrate metabolismPotassium ionsCellular and Molecular NeuroscienceBiochemistryMolecular MedicineHuman erythrocytesGlycolysisMolecular BiologyIncubationWhole bloodExperientia
researchProduct

Oxygen exchange in the erythrocyte

1969

Es wird eine Ubersicht uber die mathematischen und experimentellen Aspekte des O2-Austausches im Erythrozyten gegeben. Der Gesamtprozess kann als eine Sauerstoffdiffusion mit gekoppelter Hamoglobin-Sauerstoff-Reaktion beschrieben werden. Fur die mathematische Analyse muss also die partielle Differentialgleichung der Diffusion durch ein Gleichungssystem erweitert werden, das dem chemischen Reaktionsablauf Rechnung tragt. Voraussetzung hierfur ist die Aufstellung eines Modells zur molekularen Interpretation der O2-Bindungskurve. Die vereinfachten Differentialgleichungen fur Diffusion und Reaktion lassen sich unter Beachtung der Rand- und Anfangsbedingungen nur naherungsweise integrieren.

PharmacologyErythrocytesChemistryPartial PressureCell BiologyModels BiologicalMolecular biologyDiffusionOxygenHemoglobinsKineticsCellular and Molecular NeuroscienceHumansMolecular MedicineMolecular BiologyExperientia
researchProduct